|
Press Releases
April 10, 2003
Lab Studies Indicating That Tumors Can Be Eliminated and Immunity Induced to
be Presented to Laser Medicine and Surgery Society
KNOXVILLE, Tenn.--April 10, 2003–-Provectus Pharmaceuticals,
Inc.(OTC Bulletin Board:
PVCT -
News)
Laboratory studies indicating that a light-sensitive drug can kill tumors and
induce immunity against additional tumors will be the topic of a presentation in
Anaheim by Provectus Pharmaceuticals, Inc. on Sunday, April 13, at the annual meeting
of the American Society for Laser Medicine and Surgery.
Read the complete article here
April 1, 2003
Provectus Pharmaceuticals Awarded Fourth Genetic Engineering Patent in Seven Months
KNOXVILLE, Tenn.--(BUSINESS WIRE)--April 1, 2003-- Provectus Pharmaceuticals, Inc. (OTC Bulletin Board:
PVCT -
News)
today announced that it has received U.S. patent No. 6,541,223, covering
methods used to isolate, identify and produce previously unknown viral agents.
Read the complete article here.
March 18, 2003
Harvard and Provectus Announce Success Treating Ocular Melanoma with Laser
KNOXVILLE, Tenn.--March 18, 2003–-Provectus Pharmaceuticals, Inc.(BULLETIN BOARD:
PVCT -
News)
and the Massachusetts Eye and Ear Infirmary today announced publication
of results from extensive pre-clinical testing of Provectus' non-invasive laser
treatment for ocular melanoma.
Read the complete article here
February 25, 2003
Provectus Pharmaceuticals Gains Additional Imaging Patent
KNOXVILLE, Tenn.--(BUSINESS WIRE)--Feb. 25, 2003--Provectus Pharmaceuticals, Inc.(OTC Bulletin Board:
PVCT - News)
today announced that it has received U.S. patent No. 6,525,862, covering signal
encoding and processing equipment used for high-sensitivity biomedical imaging.
Read the complete article here
February 24, 2003
Provectus Pharmaceuticals Inc. Retains Strategic Growth International -SGI- as
Investor Relations Adviser
KNOXVILLE, Tenn.--February 24, 2003–-Provectus Pharmaceuticals, Inc.(BULLETIN BOARD:
PVCT - News)
today announced that it has appointed Strategic Growth International Inc. (SGI), with headquarters in New York,
as its investor relations adviser.
Read the complete article here.
February 13, 2003
Provectus Pharmaceuticals Gains New Optical Imaging Patent
KNOXVILLE, Tenn.--(BUSINESS WIRE)--Feb. 13, 2003--Provectus Pharmaceuticals, Inc.(OTC Bulletin Board:
PVCT -
News)
today announced that it has received U.S. patent No. 6,519,076, covering signal
encoding and processing methods that can significantly increase the sensitivity
of imaging systems used in biomedical research.
Read complete article here.
|
